While the inflammatory mechanism of lipodystrophy is relatively a new idea, overlapping aetiology between lipodystrophy and obesity might indicate that a platform of obesity treatment may well be applied to BSCL2 treatment. The gene discussed is BSCL2; the disease is obesity due to melanocortin 4 receptor deficiency.